Drug Repurposing: A Potentially Emerging Discipline
Indian Journal of Pharmaceutical Education and Research
; 56(2):S121-S136, 2022.
Article
in English
| EMBASE | ID: covidwho-1884616
ABSTRACT
Drug repurposing is the remodeling of already existing drugs to reduce the time frame, costs, and efforts in developing a new novel drug. This strategy has secured significant momentum in the previous decade. It overcomes the snags and pitfalls in the traditional means of drug discovery. This core research strategy has now become the sole approach to containing many deadly diseases that have no cure in the present. In astound, for pandemics like COVID-19 that is spreading like a wildfire worldwide, large-scale research programs and trials have been carried out to identify and modify existing drugs to counter the novel virus. Thus, this technology of drug repurposing offers a new lease of life, and greatly promotes the progress of the medicine, health, and pharma sectors. The purpose of this study is to understand the current status of drug repurposing in the field of virology, bacteriology, mycology, and oncology for clinical translatability.
artesunate; azithromycin; bepridil; celecoxib; chlorcyclizine; chloroquine; chlorpromazine; clotrimazole; daptomycin; estrogen receptor; favipiravir; floxuridine; griseofulvin; imatinib; manidipine; memantine; miconazole; mitomycin; mycophenolic acid; naftifine; niclosamide; nitazoxanide; pentamidine; prochlorperazine; rafoxanide; raltegravir; remdesivir; ribavirin; salicylamide; sitagliptin; sofosbuvir; tamoxifen; ticagrelor; toremifene; article; Dengue virus; drug repositioning; Ebolavirus; human; Human immunodeficiency virus; Influenza virus; nonhuman; Zika virus
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Indian Journal of Pharmaceutical Education and Research
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS